Trodelvy ( Sacituzumab govitecan): a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate for triple-negative breast cancer
CPE point : 1 per event
This is an in-service training for the staff of St. Teresa’s Hospital and St. Paul’s Hospital
Date:
2025-12-08
Time:
5:30pm to 6:30pm
Organising Institute:
St. Teresa’s Hospital and St. Paul’s Hospital
Speaker:
MPharm Rachel Lee, Manager, Medical Affairs, Gilead
Related CPE Activities:
